JP2023517532A5 - - Google Patents
Info
- Publication number
- JP2023517532A5 JP2023517532A5 JP2022552858A JP2022552858A JP2023517532A5 JP 2023517532 A5 JP2023517532 A5 JP 2023517532A5 JP 2022552858 A JP2022552858 A JP 2022552858A JP 2022552858 A JP2022552858 A JP 2022552858A JP 2023517532 A5 JP2023517532 A5 JP 2023517532A5
- Authority
- JP
- Japan
- Prior art keywords
- pharmaceutical composition
- composition according
- epinephrine
- type
- particles
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP2026028936A JP2026094260A (ja) | 2020-03-16 | 2026-02-25 | 粉末化された鼻腔内エピネフリンによる治療 |
Applications Claiming Priority (5)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US202062989913P | 2020-03-16 | 2020-03-16 | |
| US62/989,913 | 2020-03-16 | ||
| US17/135,528 US11400045B2 (en) | 2020-03-16 | 2020-12-28 | Treatment with powdered intranasal epinephrine |
| US17/135,528 | 2020-12-28 | ||
| PCT/IL2021/050288 WO2021186437A1 (en) | 2020-03-16 | 2021-03-16 | Treatment with powdered intranasal epinephrine |
Related Child Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2026028936A Division JP2026094260A (ja) | 2020-03-16 | 2026-02-25 | 粉末化された鼻腔内エピネフリンによる治療 |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JP2023517532A JP2023517532A (ja) | 2023-04-26 |
| JP2023517532A5 true JP2023517532A5 (cg-RX-API-DMAC7.html) | 2024-03-27 |
Family
ID=77664091
Family Applications (2)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2022552858A Pending JP2023517532A (ja) | 2020-03-16 | 2021-03-16 | 粉末化された鼻腔内エピネフリンによる治療 |
| JP2026028936A Pending JP2026094260A (ja) | 2020-03-16 | 2026-02-25 | 粉末化された鼻腔内エピネフリンによる治療 |
Family Applications After (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2026028936A Pending JP2026094260A (ja) | 2020-03-16 | 2026-02-25 | 粉末化された鼻腔内エピネフリンによる治療 |
Country Status (13)
| Country | Link |
|---|---|
| US (2) | US11400045B2 (cg-RX-API-DMAC7.html) |
| EP (1) | EP4121005A1 (cg-RX-API-DMAC7.html) |
| JP (2) | JP2023517532A (cg-RX-API-DMAC7.html) |
| KR (1) | KR20220154709A (cg-RX-API-DMAC7.html) |
| CN (1) | CN115279340A (cg-RX-API-DMAC7.html) |
| AR (1) | AR121593A1 (cg-RX-API-DMAC7.html) |
| AU (1) | AU2021239084A1 (cg-RX-API-DMAC7.html) |
| BR (1) | BR112022018440A2 (cg-RX-API-DMAC7.html) |
| CA (1) | CA3175130A1 (cg-RX-API-DMAC7.html) |
| IL (1) | IL296268A (cg-RX-API-DMAC7.html) |
| MX (1) | MX2022011464A (cg-RX-API-DMAC7.html) |
| TW (1) | TW202200119A (cg-RX-API-DMAC7.html) |
| WO (1) | WO2021186437A1 (cg-RX-API-DMAC7.html) |
Families Citing this family (11)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US11400045B2 (en) * | 2020-03-16 | 2022-08-02 | Nasus Pharma Ltd. | Treatment with powdered intranasal epinephrine |
| CN121265577A (zh) | 2020-05-18 | 2026-01-06 | 奥瑞克索股份公司 | 用于药物递送的药物组合物 |
| US12414916B2 (en) | 2021-06-10 | 2025-09-16 | Belhaven BioPharma Inc. | Dry powder formulations of epinephrine and associated methods |
| US11617716B2 (en) | 2021-06-10 | 2023-04-04 | Belhaven BioPharma Inc. | Dry powder formulations of epinephrine and associated methods |
| US12661315B2 (en) | 2021-06-10 | 2026-06-23 | Belhaven BioPharma Inc. | Dry powder formulations of epinephrine and associated methods |
| TW202333658A (zh) | 2021-11-25 | 2023-09-01 | 瑞典商奥瑞克索股份公司 | 包含腎上腺素之新穎醫藥組合物 |
| GB202117016D0 (en) | 2021-11-25 | 2022-01-12 | Orexo Ab | New pharmaceutical device |
| AU2023322235A1 (en) * | 2022-08-11 | 2025-03-13 | De Motu Cordis Pty Ltd | Inhalable epinephrine formulation |
| US12029709B2 (en) | 2022-08-11 | 2024-07-09 | De Motu Cordis Pty Ltd | Inhalable epinephrine formulation |
| KR20260016535A (ko) * | 2023-05-31 | 2026-02-03 | 오렉쏘 에이비 | 아드레날린 수용체 조절제를 포함하는 분무 건조 조성물 |
| US20260108465A1 (en) | 2024-10-21 | 2026-04-23 | Belhaven BioPharma Inc. | Compositions, devices, and methods for intranasal delivery of dry powder epinephrine |
Family Cites Families (35)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| KR940006601A (ko) | 1992-09-12 | 1994-04-25 | 야나가와 히로미 | 생리활성 펩티드 조성물 |
| US6017963A (en) | 1995-11-14 | 2000-01-25 | Euro-Celtique, S.A. | Formulation for intranasal administration |
| ATE289825T1 (de) | 1999-04-21 | 2005-03-15 | 1355540 Ontario Inc | Methacoline oder histamine formulierungen zur feststellung von asthma |
| GB2367756B (en) | 2000-10-12 | 2003-01-08 | Bespak Plc | Dispensing apparatus |
| GB2380410B (en) | 2001-10-05 | 2003-11-19 | Alchemy Healthcare Ltd | Apparatus for the nasal or oral delivery of a medicament |
| GB2384190A (en) | 2002-01-22 | 2003-07-23 | Bespak Plc | Dispensing device for a powdered product |
| US20090246281A1 (en) | 2003-11-03 | 2009-10-01 | Norton Healthcare Ltd. | Soft steroid compositions for use in dry powder inhalers |
| WO2006016530A1 (ja) | 2004-08-10 | 2006-02-16 | Translational Research, Ltd. | 速効性でかつ高い吸収性を可能とする経鼻投与用組成物 |
| GB0524194D0 (en) | 2005-11-28 | 2006-01-04 | Univ Aston | Respirable powders |
| EP1960022A1 (en) | 2005-11-29 | 2008-08-27 | Alza Corporation | Nasal delivery device for the delivery of a substance to the olfactory region |
| US20070178166A1 (en) | 2005-12-15 | 2007-08-02 | Acusphere, Inc. | Processes for making particle-based pharmaceutical formulations for pulmonary or nasal administration |
| ES2652415T3 (es) * | 2006-12-26 | 2018-02-02 | Shin Nippon Biomedical Laboratories, Ltd. | Preparación para aplicación transnasal |
| GB2448183A (en) | 2007-04-05 | 2008-10-08 | Optinose As | Nasal powder delivery device |
| WO2009050726A2 (en) | 2007-05-28 | 2009-04-23 | Panacea Biotec Limited | Compositions and methods for improved delivery of bupropion |
| RU2491067C2 (ru) | 2007-08-06 | 2013-08-27 | Байотай Терапис, Инк | Способы лечения зависимости |
| US9101539B2 (en) | 2009-05-15 | 2015-08-11 | Shin Nippon Biomedical Laboratories, Ltd. | Intranasal pharmaceutical compositions with improved pharmacokinetics |
| CN102166219B (zh) * | 2010-05-25 | 2013-04-17 | 杭州天龙药业有限公司 | 一种鼻腔给药制剂及其应用 |
| WO2012078804A1 (en) | 2010-12-07 | 2012-06-14 | Respira Therapeutics, Inc. | Dry powder inhaler |
| US9949923B2 (en) | 2011-03-15 | 2018-04-24 | Optinose As | Nasal delivery |
| US9789071B2 (en) | 2012-06-27 | 2017-10-17 | G2B Pharma, Inc. | Intranasal formulation of epinephrine for the treatment of anaphylaxis |
| WO2014134070A1 (en) | 2013-02-26 | 2014-09-04 | Baxter International Inc. | Treatment of central nervous system disorders by intranasal administration of immunoglobulin g |
| CN104274426A (zh) | 2013-07-03 | 2015-01-14 | 陆克塞纳医药公司 | 昂丹司琼细粉、昂丹司琼气溶胶组合物及其用途 |
| US20160220489A1 (en) | 2013-09-03 | 2016-08-04 | G2B Pharma Inc. | Intranasal Formulation for the Treatment of Cardiopulmonary Resuscitation (CPR), Cardiac Life Support (CLS), Anaphylaxis and/or Anaphylactoid Reactions |
| CN105979999B (zh) | 2013-12-11 | 2021-03-12 | 株式会社Jms | 阳型连接器 |
| AU2015228541B2 (en) | 2014-03-14 | 2020-09-03 | Opiant Pharmaceuticals, Inc. | Nasal drug products and methods of their use |
| US20200069582A1 (en) | 2014-07-03 | 2020-03-05 | Darren Rubin | Inhalable hemodynamic agents and methods of using the same |
| CN107205938A (zh) * | 2014-12-18 | 2017-09-26 | 温德加普医疗股份有限公司 | 用于溶解或增溶治疗剂的方法和组合物 |
| UA121874C2 (uk) | 2015-02-17 | 2020-08-10 | Елі Ліллі Енд Компані | Порошкова назальна композиція для лікування гіпоглікемії |
| EP3842457A1 (en) | 2015-09-09 | 2021-06-30 | Novartis AG | Thymic stromal lymphopoietin (tslp)-binding molecules and methods of using the molecules |
| CA3030359A1 (en) | 2016-08-05 | 2018-02-08 | Shin Nippon Biomedical Laboratories, Ltd. | Intranasal pharmaceutical powder compositions |
| CN110996912A (zh) * | 2017-08-20 | 2020-04-10 | 福摩莱克斯医药创新有限公司 | 用于鼻内递送的干粉组合物 |
| US11844859B2 (en) * | 2017-08-20 | 2023-12-19 | Nasus Pharma Ltd. | Dry powder compositions for intranasal delivery |
| ES2791775B2 (es) * | 2018-02-06 | 2023-01-20 | Aegis Therapeutics Llc | Formulaciones de epinefrina intranasal y metodos para el tratamiento de enfermedades |
| KR20200125632A (ko) * | 2018-02-26 | 2020-11-04 | 신 니뽄 바이오메디칼 라보라토리즈, 엘티디. | 분말 제제, 카트리지 및 디바이스 |
| US11400045B2 (en) * | 2020-03-16 | 2022-08-02 | Nasus Pharma Ltd. | Treatment with powdered intranasal epinephrine |
-
2020
- 2020-12-28 US US17/135,528 patent/US11400045B2/en active Active
-
2021
- 2021-03-16 BR BR112022018440A patent/BR112022018440A2/pt unknown
- 2021-03-16 AU AU2021239084A patent/AU2021239084A1/en active Pending
- 2021-03-16 MX MX2022011464A patent/MX2022011464A/es unknown
- 2021-03-16 KR KR1020227033697A patent/KR20220154709A/ko not_active Withdrawn
- 2021-03-16 JP JP2022552858A patent/JP2023517532A/ja active Pending
- 2021-03-16 IL IL296268A patent/IL296268A/en unknown
- 2021-03-16 TW TW110109439A patent/TW202200119A/zh unknown
- 2021-03-16 EP EP21714436.9A patent/EP4121005A1/en active Pending
- 2021-03-16 CN CN202180020993.7A patent/CN115279340A/zh active Pending
- 2021-03-16 CA CA3175130A patent/CA3175130A1/en active Pending
- 2021-03-16 AR ARP210100664A patent/AR121593A1/es unknown
- 2021-03-16 US US17/911,523 patent/US12678402B2/en active Active
- 2021-03-16 WO PCT/IL2021/050288 patent/WO2021186437A1/en not_active Ceased
-
2026
- 2026-02-25 JP JP2026028936A patent/JP2026094260A/ja active Pending
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| TWI583384B (zh) | 包含4-胺基-5-氟-3-[6-(4-甲基哌嗪-1-基)-1h-苯并咪唑-2-基]-1h-喹啉-2-酮乳酸鹽單水合物之醫藥組合物 | |
| US20130095180A1 (en) | Time-delayed sustained release pharmaceutical composition comprising dapoxetine for oral administration | |
| JP5911969B2 (ja) | 心臓血管障害の治療方法 | |
| JP2007533686A5 (cg-RX-API-DMAC7.html) | ||
| ES2240033T3 (es) | Comprimido matricial que permite la liberacion prolongada de trimetazidina tras su administracion oral. | |
| JP2005512995A5 (cg-RX-API-DMAC7.html) | ||
| PT2124556E (pt) | Composições farmacêuticas | |
| ES3056013T3 (en) | Bi-layer pharmaceutical tablet formulation | |
| JP2006527195A (ja) | トリプタンおよびnsaidを含む組成物 | |
| ES2324769T3 (es) | Comprimido que comprende cetrizina y pseudoefedrina. | |
| CN1972730A (zh) | 格隆溴铵用于治疗儿童哮喘 | |
| JP2005515991A (ja) | 5ht1レセプターアゴニストを含む医薬組成物 | |
| WO2005094832A1 (en) | Compositions comprising meloxicam | |
| JP2012036200A (ja) | 他の薬剤と組合せた(r,r)−ホルモテロール | |
| JP2016537364A5 (cg-RX-API-DMAC7.html) | ||
| JP5713421B1 (ja) | 口腔内崩壊錠 | |
| ES2241777T3 (es) | Composiciones farmaceuticas que contienen terbinafina. | |
| ES2582012T3 (es) | Composiciones farmacéuticas de levetiracetam | |
| KR20060109919A (ko) | 5-ht-수용체 아고니스트류를 위한 경구 제제들, 그들의용도 및 그들을 이용한 치료 방법 | |
| JP2009535336A (ja) | 片頭痛治療用の固定組合せ剤形 | |
| KR20210137484A (ko) | 캡시드 조립 조절제 고체 제형 | |
| WO2008068778A2 (en) | Extended release pharmaceutical composition of pramipexole | |
| JP2513656B2 (ja) | 血小板凝集阻止作用を有する併用組合せ製剤 | |
| PT1646373E (pt) | Composição farmacêutica orodispersível de um composto antitrombótico | |
| WO2023080910A1 (en) | Compositions containing dofetilide and mexiletine and uses thereof |